Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy
IVB therapy significantly reduced SRF in cCSC patients with secondary MNV, though it did not lead to visual improvement or significant changes in SFCT. However, greater choroidal thinning in patients with complete fluid resorption may suggest distinct underlying mechanisms or alternative sources of subretinal fluid beyond the MNV itself.
Authors
- Anat Loewenstein (ORCID: https://orcid.org/0000-0002-7706-1165)
- Shiri Shulman (ORCID: https://orcid.org/0000-0002-3188-3470)
- Omer Trivizki (ORCID: https://orcid.org/0000-0003-3887-6238)
- Gissel Herrera (ORCID: https://orcid.org/0009-0003-5105-0702)
- Oren Levine (ORCID: https://orcid.org/0000-0003-0885-3721)
- David Rabinovitch (ORCID: https://orcid.org/0000-0003-4970-7747)
- Liang Wang (ORCID: https://orcid.org/0000-0002-8761-0770)
- Prashanth G. Iyer
- Dafna Goldenberg
- Noah Igra
Institutions
- University of Miami (US)
- Tel Aviv University (IL)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-12-03
- DOI
- https://doi.org/10.3390/biomedicines12122760
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.54